Cargando…
Coexistence of breakpoint cluster region-Abelson1 rearrangement and Janus kinase 2 V617F mutation in chronic myeloid leukemia: A case report
BACKGROUND: The Janus kinase 2 (JAK2) V617F mutation is common in patients with breakpoint cluster region-Abelson1 (BCR-ABL1)-negative myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and primary myelofibrosis, but is rarely detected in BCR-ABL1-positive chronic m...
Autores principales: | Shi, Xue-Bing, Jiang, Ji-Fa, Jin, Feng-Xiang, Cheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511928/ https://www.ncbi.nlm.nih.gov/pubmed/31123683 http://dx.doi.org/10.12998/wjcc.v7.i9.1087 |
Ejemplares similares
-
Mutations in the breakpoint cluster region-Abelson murine leukemia 1 gene in Brazilian patients with chronic myeloid leukemia
por: Costa, Heloísa Zorzi, et al.
Publicado: (2018) -
Comparative Expression
Analysis of Breakpoint Cluster
Region–Abelson Oncogene in Leukemia Patients
por: Arshad, Farah, et al.
Publicado: (2023) -
A comprehensive analysis of breakpoint cluster region-abelson fusion oncogene splice variants in chronic myeloid leukemia and their correlation with disease biology
por: Iqbal, Zafar
Publicado: (2014) -
Janus Kinase V617F Mutation Detection in Patients with Myelofibrosis
por: Nikolova, D, et al.
Publicado: (2019) -
Efficacy of the polo-like kinase inhibitor rigosertib, alone or in combination with Abelson tyrosine kinase inhibitors, against break point cluster region-c-Abelson-positive leukemia cells
por: Okabe, Seiichi, et al.
Publicado: (2015)